POP Biotechnologies, Inc. Press Releases - EIN Presswire

Published on July 24, 2025 - 22:18 GMT

POP BIO and CEPI announce collaboration for faster responses to Disease X

POP BIO announces an award of up to $1.5M award from CEPI to advance the SNAP platform into the development of a SFTS vaccine BUFFALO, NY, UNITED STATES, July 24, 2025 /⁨EINPresswire.com⁩/ -- ‍New research is set to investigate a pioneering approach using …

Distribution channels: Companies, Emergency Services ...

Published on November 26, 2024 - 15:30 GMT

POP BIO awarded $2.84M Phase II SBIR for seasonal influenza vaccine development

BUFFALO, NY, UNITED STATES, November 26, 2024 /⁨EINPresswire.com⁩/ -- POP Biotechnologies Inc. (POP BIO) received a $2.84M Phase II SBIR under award number 1R44AI181479-01, supported by the National Institute of Allergies and Infectious Disease (NIAID), …

Distribution channels: Business & Economy, Companies ...

Published on September 10, 2024 - 22:13 GMT

POP BIO announces findings for an Alzheimer’s Disease polyvalent peptide immunotherapy

POP BIO announces publication of “A pentavalent peptide vaccine elicits Aβ and tau antibodies with prophylactic activity in an Alzheimer’s disease mouse model” BUFFALO, NY, UNITED STATES, September 10, 2024 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP …

Distribution channels: Business & Economy, Companies ...

Published on August 21, 2024 - 15:00 GMT

POP BIO and FunPep Announce Collaboration for Antibody-Inducing Peptide Therapy

POP Biotechnologies announces the furtherance of research with FunPep. Advanced preclinical testing of antibody-inducing peptides will be carried out. BUFFALO, NY, 14228, August 21, 2024 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP BIO), a Buffalo, NY …

Distribution channels: Business & Economy, Companies ...

Published on August 7, 2024 - 16:16 GMT

POP BIO and EuBiologics’ Shingles Vaccine Enters Phase 1 Clinical Trials

POP Biotechnologies announces the commencement of dosing of the shingles vaccine “EuHZV” in collaboration with EuBiologics in a Phase 1 clinical study in Korea BUFFALO, NY, UNITED STATES, August 7, 2024 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP BIO …

Distribution channels: Business & Economy, Companies ...

Published on June 27, 2023 - 17:07 GMT

POP BIO and EuBiologics’ EuCorVac-19 COVID-19 vaccine hits target in Phase 3 trial

POP Biotechnologies (POP BIO), a Buffalo, NY-based biopharmaceutical startup, announces top line interim results of a Phase 3 clinical trial of EuCorVac-19 BUFFALO, NY, UNITED STATES, June 27, 2023 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP BIO), a …

Distribution channels: Business & Economy, Companies ...

Published on November 30, 2022 - 18:58 GMT

POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19

POP Biotechnologies (POP BIO), a biopharmaceutical startup, announces the publication of an interim analysis of the Phase 2 clinical trial of EuCorVac-19. BUFFALO, NY, UNITED STATES, November 30, 2022 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP BIO …

Distribution channels: Companies, Education ...

Published on September 21, 2022 - 18:35 GMT

POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19

POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19 with Eubiologic's EuCorVac-19 BUFFALO, NY, USA, September 21, 2022 /⁨EINPresswire.com⁩/ -- POP Biotechnologies (POP BIO), a Buffalo, New York- …

Distribution channels: Companies, Healthcare & Pharmaceuticals Industry ...